Analysis of clinical datasets confirmed that PRMT7 and SOX9 are upregulated in human NSCLC specimens, and their elevated expression was associated with poor patient prognosis, highlighting the translational relevance of this axis. Here, PRMT7 is linked to non-small cell lung carcinoma.